A New York-based Medicare Advantage plan has formally contested the federal government’s decision to downgrade its Star Ratings, arguing the evaluation unfairly penalizes the plan for factors beyond its control. The challenge highlights ongoing disputes over the methodology used by the Centers for Medicare & Medicaid Services (CMS) to assess plan performance, particularly in areas like customer satisfaction and health outcomes. Legal experts suggest the case could set a precedent for how insurers respond to rating adjustments tied to broader systemic issues, such as pandemic-related disruptions. The outcome may influence future regulatory approaches to evaluating Medicare plans nationwide.
New York Medicare Plan Challenges HHS Star Rating Decision Bloomberg Law News
